Status:
WITHDRAWN
A Behavioral Intervention for Depression and Chronic Pain in Primary Care (Relief-Hybrid)
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Chronic Pain
Depression
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Chronic pain and depression frequently co-exist in late and mid-life and contribute to increased disability, high health care costs, psychiatric comorbidity, and suicide. Older and middle-aged depress...
Eligibility Criteria
Inclusion
- 50 years or older
- PHQ-9 score greater or equal to 10
- Chronic pain (non-cancer related, most days over the past 3 months)
- Capacity to consent
Exclusion
- DSM-5 Axis 1 diagnoses other than depression and anxiety disorders
- Montreal Cognitive Assessment (MoCA) \< 24
- Active suicidal ideation (MADRS item #10 greater or equal to 4
- Severe or life-threatening medical illness
- Patients on psychotropics, opioids or benzodiazepines will be included if they do not meet DSM-5 criteria for opioid, anxiolytics or other substance abuse disorders
Key Trial Info
Start Date :
February 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04290845
Start Date
February 1 2023
End Date
December 1 2024
Last Update
March 24 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Internal Medical Associates (WCIMA)
New York, New York, United States, 10021
2
Iris Cantor Men's and Women's Health Centers
New York, New York, United States, 10065
3
Irving Sherwood Wright Center
New York, New York, United States, 10075
4
Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine
White Plains, New York, United States, 10605